Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase

AUTOR(ES)

Castro Faria Neto, Hugo C, Stafforini, Diana M, Prescott, Stephen M, Zimmerman, Guy A

FONTE

Memórias do Instituto Oswaldo Cruz

DATA DE PUBLICAÇÃO

2005-03

RESUMO

Platelet-activating factor (PAF) is one of the most potent lipid mediators involved in inflammatory events. The acetyl group at the sn-2 position of its glycerol backbone is essential for its biological activity. Deacetylation induces the formation of the inactive metabolite lyso-PAF. This deacetylation reaction is catalyzed by PAF-acetylhydrolase (PAF-AH), a calcium independent phospholipase A2 that also degrades a family of PAF-like oxidized phospholipids with short sn-2 residues. Biochemical and enzymological evaluations revealed that at least three types of PAF-AH exist in mammals, namely the intracellular types I and II and a plasma type. Many observations indicate that plasma PAF AH terminates signals by PAF and oxidized PAF-like lipids and thereby regulates inflammatory responses. In this review, we will focus on the potential of PAF-AH as a modulator of diseases of dysregulated inflammation.

Documentos Relacionados

• Type II platelet-activating factor-acetylhydrolase is essential for epithelial morphogenesis in Caenorhabditis elegans
• Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.
• Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
• Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma
• Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.